Illumina and ReaMetrix to Collaborate on Molecular Diagnostics and Market Development
Illumina, Inc. and ReaMetrix, Inc. announced the formation of a diagnostic collaboration under which the companies plan to co-develop molecular diagnostic panels for a range of disease areas. Under the terms of the agreement, ReaMetrix will gain non-exclusive rights to market the resulting panels to the country of India and its more than one billion inhabitants. Illumina will retain rights to market the tests outside of India.
Illumina will supply VeraCode(TM) technology and other reagents for the tests. ReaMetrix will develop, validate and market diagnostic panels based on Illumina's upcoming BeadXpress(TM) platform, scheduled for market introduction before the end of the calendar year.
ReaMetrix will drive market development activities from its operation in Bangalore, India. According to Bala Manian, Ph.D., ReaMetrix Chief Executive Officer, "India's rapidly emerging healthcare system presents a tremendous opportunity to leapfrog current diagnostics and chart a new path with innovative molecular and pharmacogenomic testing. Teaming up with Illumina and its BeadXpress diagnostic platform, we see a significant opportunity to drive the evolution toward the efficiencies inherent in targeted, personalized medicine. In targeting the wide-open Indian market, we will be creating products that will drive value the world over."
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
